Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
Background. Novel potential small molecular biomarkers for sepsis were analyzed with nontargeted metabolite profiling to find biomarkers for febrile neutropenia after intensive chemotherapy for hematological malignancies. Methods. Altogether, 85 patients were included into this prospective study at...
Main Authors: | Marika Lappalainen, Jenna Jokkala, Auni Juutilainen, Sari Hämäläinen, Irma Koivula, Esa Jantunen, Kati Hanhineva, Kari Pulkki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2018/6964529 |
Similar Items
-
Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
by: Sini Korpelainen, et al.
Published: (2017-01-01) -
Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01) -
Tratamento ambulatorial da neutropenia febril Outpatient treatment with intravenous antimicrobial therapy in patients with febrile neutropenia and hematologic malignancies
by: Marcelo Bellesso
Published: (2009-01-01) -
Standart and Lipozomal Amphotericin B in Febrile Neutropenia with Hematological Malignancies
by: H. Şenol COŞKUN, et al.
Published: (1998-06-01) -
NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
by: Pio Lopez, et al.
Published: (2008-03-01)